Latest AI and machine learning research in allergy for healthcare professionals.
PURPOSE: The clinical outcome of urothelial carcinoma presents significant variability, reflecting its molecular composition, epidemiologic attributes, and primary site of origin. Despite histological similarities, upper tract urothelial carcinoma (UTUC) and bladder urothelial carcinoma (BLCA) represent two distinct disease entities with disparate treatment responses and mutational patterns. MATER...
BACKGROUND: The AI-HOPE Lung Cancer study is a multicenter initiative designed to integrate artificial intelligence (AI) and real-world data to improve outcome prediction in patients with metastatic non-small-cell lung cancer treated with first-line immunotherapy-based regimens. AI-HOPE aims to leverage machine learning (ML) models to generate individualized predictions of progression-free surviva...
Despite remarkable advances in cancer drug treatment, including chemotherapy, targeted therapy, and immunotherapy, therapeutic resistance remains a fo...
The T-cell receptor (TCR) repertoire records an individual's immunological history, but most unique CDR3 sequences in any one person are private and u...
Breast cancer is a complex and heterogeneous disease that remains a major global health challenge. Recent progress in molecular biology, artificial in...
INTRODUCTION: Atopic Dermatitis (AD) is a chronic inflammatory skin disease characterized by complex pathogenesis, variable clinical phenotypes, and b...
The gut microbiota constitutes a highly complex ecosystem that plays a pivotal role in maintaining human health and modulating the immune response. Dy...
The immune system plays crucial role to fight against cancer. Still, cancer cells have evolved mechanisms to evade immune responses, especially throug...
PURPOSE: Exogenous chemical exposure is closely associated with allergic rhinitis (AR). Methyl 4-hydroxybenzoate (MeP), a widely used preservative, po...
Accurate assessment of the severity of atopic dermatitis is crucial for guiding treatment. However, the Eczema Area and Severity Index (EASI), a widel...
Colorectal cancer (CRC) is molecularly and immunologically heterogeneous, contributing to variable treatment response. Because regulated cell death (R...
Fluorodeoxyglucose PET/computed tomography plays a central role in the management of melanoma and soft-tissue sarcoma by enabling comprehensive metabo...
PURPOSE OF REVIEW: The heterogeneity of response to immunotherapies in renal cell carcinoma has created a strong need for predictive biomarkers to gui...
Hepato-biliary-pancreatic cancers, notorious for their pronounced heterogeneity and poor prognosis, continue to be a dominant factor in cancer-related...
INTRODUCTION: Hepatocellular carcinoma (HCC) is a highly aggressive malignancy characterized by limited therapeutic options and significant cellular h...
Cancer stem-like cells (CSCs) play a pivotal role in driving tumor heterogeneity, therapeutic resistance, and disease progression. Despite the power o...
Atopic dermatitis (AD) is a chronic inflammatory skin disorder with complex pathogenesis, and current therapies face limitations in efficacy and safet...
BACKGROUND: Results from the IMPACT trial suggest that initiation of peanut oral immunotherapy (pnOIT) before age 4 years can increase chances of achi...
Immune check-point inhibitors (ICIs) have outstandingly changed the treatment for lung cancer patients providing longer progression-free (PFS) and ove...
Bladder cancer (BC) exhibits profound molecular heterogeneity and a highly dynamic tumor microenvironment, posing major challenges for effective thera...